Medicine & TechnologyResearch shows that a lower dose of blood thinners in the COVID-19 ICU patients is similarly effective in preventing blood clots and has a lower risk of bleeding.
The Omicron subvariant BA.2 has been detected in almost 50 countries in which more than 10,000 people are infected globally. Scientists are still monitoring this new variant while also understanding its immune escape and virulence.
Some studies have recently suggested that up to 50 percent of all people who have overcome infection experience symptoms of long COVID, which include chest pains, tiredness, difficulty breathing, loss of taste or smell, and sore joints.
Scientists recently discovered that there may be a connection between the current global health crisis and the reduced incidence of lightning reported during the worldwide shutdown during last year's spring season.
Researchers found that the anticoagulant heparin could help treat COVID-19 patients as it improves symptoms and increase oxygen levels in the lungs by about 70%.
Various companies are enthusiastic about receiving a favorable effect with less intrusive, more standardized gut infection treatment that could attain approval from the United Nations regulatory.
Vaccine maker Moderna recently said it is hoping to sell a combined booster jab for infectious diseases such as COVID-19, influenza, and a common respiratory virus known as RSV.
A Canadian study recently showed that 50 percent more blood cells are destroyed when traveling in space and this continues for however long the mission takes.
The Chinese Buffet, located northwest of England, provides contactless food service through BellaBots, an AI-powered machine that is cheaper than hiring a human employee.
The head of South Africa's Medical Research Council or SAMRC, Glenda Gray recently claimed that the COVID-19 vaccine booster shot developed by Johnson and Johnson has 85-percent efficacy.